Global Clinical Oncology Next Generation Sequencing Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Clinical Oncology Next Generation Sequencing Market Size 2017-2028

2.1.2 Clinical Oncology Next Generation Sequencing Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Clinical Oncology Next Generation Sequencing Segment by Type

2.2.1 Whole Genome Sequencing

2.2.2 Whole Exome Sequencing

2.2.3 Targeted Sequencing & Resequencing Centrifuges

2.3 Clinical Oncology Next Generation Sequencing Market Size by Type

2.3.1 Clinical Oncology Next Generation Sequencing Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Clinical Oncology Next Generation Sequencing Market Size Market Share by Type (2017-2022)

2.4 Clinical Oncology Next Generation Sequencing Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Laboratories

2.5 Clinical Oncology Next Generation Sequencing Market Size by Application

2.5.1 Clinical Oncology Next Generation Sequencing Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Clinical Oncology Next Generation Sequencing Market Size Market Share by Application (2017-2022)

3 Clinical Oncology Next Generation Sequencing Market Size by Player

3.1 Clinical Oncology Next Generation Sequencing Market Size Market Share by Players

3.1.1 Global Clinical Oncology Next Generation Sequencing Revenue by Players (2020-2022)

3.1.2 Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Players (2020-2022)

3.2 Global Clinical Oncology Next Generation Sequencing Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Clinical Oncology Next Generation Sequencing by Regions

4.1 Clinical Oncology Next Generation Sequencing Market Size by Regions (2017-2022)

4.2 Americas Clinical Oncology Next Generation Sequencing Market Size Growth (2017-2022)

4.3 APAC Clinical Oncology Next Generation Sequencing Market Size Growth (2017-2022)

4.4 Europe Clinical Oncology Next Generation Sequencing Market Size Growth (2017-2022)

4.5 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size Growth (2017-2022)

5 Americas

5.1 Americas Clinical Oncology Next Generation Sequencing Market Size by Country (2017-2022)

5.2 Americas Clinical Oncology Next Generation Sequencing Market Size by Type (2017-2022)

5.3 Americas Clinical Oncology Next Generation Sequencing Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Clinical Oncology Next Generation Sequencing Market Size by Region (2017-2022)

6.2 APAC Clinical Oncology Next Generation Sequencing Market Size by Type (2017-2022)

6.3 APAC Clinical Oncology Next Generation Sequencing Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Clinical Oncology Next Generation Sequencing by Country (2017-2022)

7.2 Europe Clinical Oncology Next Generation Sequencing Market Size by Type (2017-2022)

7.3 Europe Clinical Oncology Next Generation Sequencing Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Clinical Oncology Next Generation Sequencing by Region (2017-2022)

8.2 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Type (2017-2022)

8.3 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Clinical Oncology Next Generation Sequencing Market Forecast

10.1 Global Clinical Oncology Next Generation Sequencing Forecast by Regions (2023-2028)

10.1.1 Global Clinical Oncology Next Generation Sequencing Forecast by Regions (2023-2028)

10.1.2 Americas Clinical Oncology Next Generation Sequencing Forecast

10.1.3 APAC Clinical Oncology Next Generation Sequencing Forecast

10.1.4 Europe Clinical Oncology Next Generation Sequencing Forecast

10.1.5 Middle East & Africa Clinical Oncology Next Generation Sequencing Forecast

10.2 Americas Clinical Oncology Next Generation Sequencing Forecast by Country (2023-2028)

10.2.1 United States Clinical Oncology Next Generation Sequencing Market Forecast

10.2.2 Canada Clinical Oncology Next Generation Sequencing Market Forecast

10.2.3 Mexico Clinical Oncology Next Generation Sequencing Market Forecast

10.2.4 Brazil Clinical Oncology Next Generation Sequencing Market Forecast

10.3 APAC Clinical Oncology Next Generation Sequencing Forecast by Region (2023-2028)

10.3.1 China Clinical Oncology Next Generation Sequencing Market Forecast

10.3.2 Japan Clinical Oncology Next Generation Sequencing Market Forecast

10.3.3 Korea Clinical Oncology Next Generation Sequencing Market Forecast

10.3.4 Southeast Asia Clinical Oncology Next Generation Sequencing Market Forecast

10.3.5 India Clinical Oncology Next Generation Sequencing Market Forecast

10.3.6 Australia Clinical Oncology Next Generation Sequencing Market Forecast

10.4 Europe Clinical Oncology Next Generation Sequencing Forecast by Country (2023-2028)

10.4.1 Germany Clinical Oncology Next Generation Sequencing Market Forecast

10.4.2 France Clinical Oncology Next Generation Sequencing Market Forecast

10.4.3 UK Clinical Oncology Next Generation Sequencing Market Forecast

10.4.4 Italy Clinical Oncology Next Generation Sequencing Market Forecast

10.4.5 Russia Clinical Oncology Next Generation Sequencing Market Forecast

10.5 Middle East & Africa Clinical Oncology Next Generation Sequencing Forecast by Region (2023-2028)

10.5.1 Egypt Clinical Oncology Next Generation Sequencing Market Forecast

10.5.2 South Africa Clinical Oncology Next Generation Sequencing Market Forecast

10.5.3 Israel Clinical Oncology Next Generation Sequencing Market Forecast

10.5.4 Turkey Clinical Oncology Next Generation Sequencing Market Forecast

10.5.5 GCC Countries Clinical Oncology Next Generation Sequencing Market Forecast

10.6 Global Clinical Oncology Next Generation Sequencing Forecast by Type (2023-2028)

10.7 Global Clinical Oncology Next Generation Sequencing Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Illumina, Inc.

11.1.1 Illumina, Inc. Company Information

11.1.2 Illumina, Inc. Clinical Oncology Next Generation Sequencing Product Offered

11.1.3 Illumina, Inc. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Illumina, Inc. Main Business Overview

11.1.5 Illumina, Inc. Latest Developments

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Information

11.2.2 Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Product Offered

11.2.3 Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Thermo Fisher Scientific Main Business Overview

11.2.5 Thermo Fisher Scientific Latest Developments

11.3 F. Hoffmann-La Roche Ltd.

11.3.1 F. Hoffmann-La Roche Ltd. Company Information

11.3.2 F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Product Offered

11.3.3 F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 F. Hoffmann-La Roche Ltd. Main Business Overview

11.3.5 F. Hoffmann-La Roche Ltd. Latest Developments

11.4 Agilent Technologies

11.4.1 Agilent Technologies Company Information

11.4.2 Agilent Technologies Clinical Oncology Next Generation Sequencing Product Offered

11.4.3 Agilent Technologies Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Agilent Technologies Main Business Overview

11.4.5 Agilent Technologies Latest Developments

11.5 Myriad Genetics

11.5.1 Myriad Genetics Company Information

11.5.2 Myriad Genetics Clinical Oncology Next Generation Sequencing Product Offered

11.5.3 Myriad Genetics Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Myriad Genetics Main Business Overview

11.5.5 Myriad Genetics Latest Developments

11.6 Beijing Genomics Institute (BGI)

11.6.1 Beijing Genomics Institute (BGI) Company Information

11.6.2 Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Product Offered

11.6.3 Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Beijing Genomics Institute (BGI) Main Business Overview

11.6.5 Beijing Genomics Institute (BGI) Latest Developments

11.7 Perkin Elmer

11.7.1 Perkin Elmer Company Information

11.7.2 Perkin Elmer Clinical Oncology Next Generation Sequencing Product Offered

11.7.3 Perkin Elmer Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Perkin Elmer Main Business Overview

11.7.5 Perkin Elmer Latest Developments

11.8 Foundation Medicine

11.8.1 Foundation Medicine Company Information

11.8.2 Foundation Medicine Clinical Oncology Next Generation Sequencing Product Offered

11.8.3 Foundation Medicine Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Foundation Medicine Main Business Overview

11.8.5 Foundation Medicine Latest Developments

11.9 Pacific Bioscience

11.9.1 Pacific Bioscience Company Information

11.9.2 Pacific Bioscience Clinical Oncology Next Generation Sequencing Product Offered

11.9.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Pacific Bioscience Main Business Overview

11.9.5 Pacific Bioscience Latest Developments

11.10 Oxford Nanopore Technologies Ltd.

11.10.1 Oxford Nanopore Technologies Ltd. Company Information

11.10.2 Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Product Offered

11.10.3 Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Oxford Nanopore Technologies Ltd. Main Business Overview

11.10.5 Oxford Nanopore Technologies Ltd. Latest Developments

11.11 Paradigm Diagnostics

11.11.1 Paradigm Diagnostics Company Information

11.11.2 Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Product Offered

11.11.3 Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Paradigm Diagnostics Main Business Overview

11.11.5 Paradigm Diagnostics Latest Developments

11.12 Caris Life Sciences

11.12.1 Caris Life Sciences Company Information

11.12.2 Caris Life Sciences Clinical Oncology Next Generation Sequencing Product Offered

11.12.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Caris Life Sciences Main Business Overview

11.12.5 Caris Life Sciences Latest Developments

11.13 Partek, Inc.

11.13.1 Partek, Inc. Company Information

11.13.2 Partek, Inc. Clinical Oncology Next Generation Sequencing Product Offered

11.13.3 Partek, Inc. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Partek, Inc. Main Business Overview

11.13.5 Partek, Inc. Latest Developments

11.14 Eurofins Scientific S.E.

11.14.1 Eurofins Scientific S.E. Company Information

11.14.2 Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Product Offered

11.14.3 Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Eurofins Scientific S.E. Main Business Overview

11.14.5 Eurofins Scientific S.E. Latest Developments

11.15 Qiagen N.V.

11.15.1 Qiagen N.V. Company Information

11.15.2 Qiagen N.V. Clinical Oncology Next Generation Sequencing Product Offered

11.15.3 Qiagen N.V. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Qiagen N.V. Main Business Overview

11.15.5 Qiagen N.V. Latest Developments

12 Research Findings and Conclusion

Table 1. Clinical Oncology Next Generation Sequencing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Whole Genome Sequencing

Table 3. Major Players of Whole Exome Sequencing

Table 4. Major Players of Targeted Sequencing & Resequencing Centrifuges

Table 5. Clinical Oncology Next Generation Sequencing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Clinical Oncology Next Generation Sequencing Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Clinical Oncology Next Generation Sequencing Market Size Market Share by Type (2017-2022)

Table 8. Clinical Oncology Next Generation Sequencing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Clinical Oncology Next Generation Sequencing Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Clinical Oncology Next Generation Sequencing Market Size Market Share by Application (2017-2022)

Table 11. Global Clinical Oncology Next Generation Sequencing Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Player (2020-2022)

Table 13. Clinical Oncology Next Generation Sequencing Key Players Head office and Products Offered

Table 14. Clinical Oncology Next Generation Sequencing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Clinical Oncology Next Generation Sequencing Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Clinical Oncology Next Generation Sequencing Market Size Market Share by Regions (2017-2022)

Table 19. Americas Clinical Oncology Next Generation Sequencing Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Clinical Oncology Next Generation Sequencing Market Size Market Share by Country (2017-2022)

Table 21. Americas Clinical Oncology Next Generation Sequencing Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Clinical Oncology Next Generation Sequencing Market Size Market Share by Type (2017-2022)

Table 23. Americas Clinical Oncology Next Generation Sequencing Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Clinical Oncology Next Generation Sequencing Market Size Market Share by Application (2017-2022)

Table 25. APAC Clinical Oncology Next Generation Sequencing Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Clinical Oncology Next Generation Sequencing Market Size Market Share by Region (2017-2022)

Table 27. APAC Clinical Oncology Next Generation Sequencing Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Clinical Oncology Next Generation Sequencing Market Size Market Share by Type (2017-2022)

Table 29. APAC Clinical Oncology Next Generation Sequencing Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Clinical Oncology Next Generation Sequencing Market Size Market Share by Application (2017-2022)

Table 31. Europe Clinical Oncology Next Generation Sequencing Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Clinical Oncology Next Generation Sequencing Market Size Market Share by Country (2017-2022)

Table 33. Europe Clinical Oncology Next Generation Sequencing Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Clinical Oncology Next Generation Sequencing Market Size Market Share by Type (2017-2022)

Table 35. Europe Clinical Oncology Next Generation Sequencing Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Clinical Oncology Next Generation Sequencing Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Clinical Oncology Next Generation Sequencing

Table 44. Key Market Challenges & Risks of Clinical Oncology Next Generation Sequencing

Table 45. Key Industry Trends of Clinical Oncology Next Generation Sequencing

Table 46. Global Clinical Oncology Next Generation Sequencing Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Clinical Oncology Next Generation Sequencing Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Clinical Oncology Next Generation Sequencing Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Clinical Oncology Next Generation Sequencing Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Clinical Oncology Next Generation Sequencing Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Clinical Oncology Next Generation Sequencing Market Size Market Share Forecast by Application (2023-2028)

Table 52. Illumina, Inc. Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors

Table 53. Illumina, Inc. Clinical Oncology Next Generation Sequencing Product Offered

Table 54. Illumina, Inc. Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Illumina, Inc. Main Business

Table 56. Illumina, Inc. Latest Developments

Table 57. Thermo Fisher Scientific Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors

Table 58. Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Product Offered

Table 59. Thermo Fisher Scientific Main Business

Table 60. Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Thermo Fisher Scientific Latest Developments

Table 62. F. Hoffmann-La Roche Ltd. Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors

Table 63. F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Product Offered

Table 64. F. Hoffmann-La Roche Ltd. Main Business

Table 65. F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. F. Hoffmann-La Roche Ltd. Latest Developments

Table 67. Agilent Technologies Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors

Table 68. Agilent Technologies Clinical Oncology Next Generation Sequencing Product Offered

Table 69. Agilent Technologies Main Business

Table 70. Agilent Technologies Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Agilent Technologies Latest Developments

Table 72. Myriad Genetics Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors

Table 73. Myriad Genetics Clinical Oncology Next Generation Sequencing Product Offered

Table 74. Myriad Genetics Main Business

Table 75. Myriad Genetics Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Myriad Genetics Latest Developments

Table 77. Beijing Genomics Institute (BGI) Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors

Table 78. Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Product Offered

Table 79. Beijing Genomics Institute (BGI) Main Business

Table 80. Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Beijing Genomics Institute (BGI) Latest Developments

Table 82. Perkin Elmer Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors

Table 83. Perkin Elmer Clinical Oncology Next Generation Sequencing Product Offered

Table 84. Perkin Elmer Main Business

Table 85. Perkin Elmer Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Perkin Elmer Latest Developments

Table 87. Foundation Medicine Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors

Table 88. Foundation Medicine Clinical Oncology Next Generation Sequencing Product Offered

Table 89. Foundation Medicine Main Business

Table 90. Foundation Medicine Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Foundation Medicine Latest Developments

Table 92. Pacific Bioscience Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors

Table 93. Pacific Bioscience Clinical Oncology Next Generation Sequencing Product Offered

Table 94. Pacific Bioscience Main Business

Table 95. Pacific Bioscience Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Pacific Bioscience Latest Developments

Table 97. Oxford Nanopore Technologies Ltd. Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors

Table 98. Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Product Offered

Table 99. Oxford Nanopore Technologies Ltd. Main Business

Table 100. Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Oxford Nanopore Technologies Ltd. Latest Developments

Table 102. Paradigm Diagnostics Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors

Table 103. Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Product Offered

Table 104. Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Paradigm Diagnostics Main Business

Table 106. Paradigm Diagnostics Latest Developments

Table 107. Caris Life Sciences Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors

Table 108. Caris Life Sciences Clinical Oncology Next Generation Sequencing Product Offered

Table 109. Caris Life Sciences Main Business

Table 110. Caris Life Sciences Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 111. Caris Life Sciences Latest Developments

Table 112. Partek, Inc. Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors

Table 113. Partek, Inc. Clinical Oncology Next Generation Sequencing Product Offered

Table 114. Partek, Inc. Main Business

Table 115. Partek, Inc. Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. Partek, Inc. Latest Developments

Table 117. Eurofins Scientific S.E. Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors

Table 118. Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Product Offered

Table 119. Eurofins Scientific S.E. Main Business

Table 120. Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 121. Eurofins Scientific S.E. Latest Developments

Table 122. Qiagen N.V. Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors

Table 123. Qiagen N.V. Clinical Oncology Next Generation Sequencing Product Offered

Table 124. Qiagen N.V. Main Business

Table 125. Qiagen N.V. Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 126. Qiagen N.V. Latest Developments

List of Figures

Figure 1. Clinical Oncology Next Generation Sequencing Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Clinical Oncology Next Generation Sequencing Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Clinical Oncology Next Generation Sequencing Market Size Market Share by Type in 2021

Figure 7. Clinical Oncology Next Generation Sequencing in Hospitals

Figure 8. Global Clinical Oncology Next Generation Sequencing Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Clinical Oncology Next Generation Sequencing in Clinics

Figure 10. Global Clinical Oncology Next Generation Sequencing Market: Clinics (2017-2022) & ($ Millions)

Figure 11. Clinical Oncology Next Generation Sequencing in Laboratories

Figure 12. Global Clinical Oncology Next Generation Sequencing Market: Laboratories (2017-2022) & ($ Millions)

Figure 13. Global Clinical Oncology Next Generation Sequencing Market Size Market Share by Application in 2021

Figure 14. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Player in 2021

Figure 15. Global Clinical Oncology Next Generation Sequencing Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Clinical Oncology Next Generation Sequencing Market Size 2017-2022 ($ Millions)

Figure 17. APAC Clinical Oncology Next Generation Sequencing Market Size 2017-2022 ($ Millions)

Figure 18. Europe Clinical Oncology Next Generation Sequencing Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size 2017-2022 ($ Millions)

Figure 20. Americas Clinical Oncology Next Generation Sequencing Value Market Share by Country in 2021

Figure 21. Americas Clinical Oncology Next Generation Sequencing Consumption Market Share by Type in 2021

Figure 22. Americas Clinical Oncology Next Generation Sequencing Market Size Market Share by Application in 2021

Figure 23. United States Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Clinical Oncology Next Generation Sequencing Market Size Market Share by Region in 2021

Figure 28. APAC Clinical Oncology Next Generation Sequencing Market Size Market Share by Application in 2021

Figure 29. China Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Clinical Oncology Next Generation Sequencing Market Size Market Share by Country in 2021

Figure 36. Europe Clinical Oncology Next Generation Sequencing Market Size Market Share by Type in 2021

Figure 37. Europe Clinical Oncology Next Generation Sequencing Market Size Market Share by Application in 2021

Figure 38. Germany Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size Market Share by Application in 2021

Figure 46. Egypt Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Clinical Oncology Next Generation Sequencing Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 52. APAC Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 53. Europe Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 55. United States Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 56. Canada Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 59. China Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 60. Japan Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 61. Korea Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 63. India Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 64. Australia Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 65. Germany Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 66. France Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 67. UK Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 68. Italy Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 69. Russia Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 70. Spain Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 73. Israel Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Clinical Oncology Next Generation Sequencing Market Size 2023-2028 ($ Millions)